TIDMCRWN 
 
 
   Crown Place VCT PLC 
 
   LEI number: 213800SYIQPA3L3T1Q68 
 
   Crown Place VCT PLC (the "Company") today makes public its information 
relating to the Half-yearly Financial Report (which is unaudited) for 
the six months to 31 December 2019. This announcement was approved by 
the Board of Directors on 20 February 2020. 
 
   The full Half-yearly Financial Report for the period to 31 December 2019 
will shortly be sent to shareholders and will be available on the Albion 
Capital Group LLP website by clicking 
https://www.globenewswire.com/Tracker?data=4EQENyfAv-ilXByUn09DjObhkaBQYrn4Aa-2xkvkKxFLSTtCr_IwyUojeE6h1Y0Ew_nL5WzXMCj8stNAIxm2qje6nQarFZcfw_NLZlZsHtLnv7ZJLjUXWqnGfwxNzjmP6C-aodv6tzrfe0Lds41GHm36bJqNFOF1WzwdK0hFoA0= 
www.albion.capital/funds/CRWN/31Dec19.pdf. 
 
   Investment policy 
 
   The Company invests in a broad portfolio of smaller, unquoted growth 
businesses across a variety of sectors including higher risk technology 
companies. Investments take the form of equity or a mixture of equity 
and loans. 
 
   Whilst allocation of funds is determined by the investment opportunities 
which are available, efforts are made to ensure that the portfolio is 
diversified both in terms of sector and stage of maturity of investee 
businesses. Funds held pending investment or for liquidity purposes are 
principally held as cash on deposit. 
 
   Risk diversification and maximum exposures 
 
   Risk is spread by investing in a number of different businesses within 
venture capital trust qualifying industry sectors using a mixture of 
securities, as permitted. The maximum amount which the Company will 
invest in a single portfolio company is 15 per cent. of the Company's 
assets at cost thus ensuring a spread of investment risk. The value of 
an individual investment may increase over time as a result of trading 
progress and it is possible that it may grow in value to a point where 
it represents a significantly higher proportion of total assets prior to 
a realisation opportunity being available. 
 
   The Company's maximum exposure in relation to gearing is restricted to 
the amount of its adjusted share capital and reserves. The Directors do 
not have any intention of utilising long-term gearing. 
 
   Financial calendar 
 
 
 
 
Record date for second dividend   6 March 2020 
 
Payment of second dividend       31 March 2020 
 
Financial year end                30 June 2020 
 
 
   Financial highlights 
 
 
 
 
                       Six months ended   Six months ended      Year ended 
                       31 December 2019   31 December 2018     30 June 2019 
                       (pence per share)  (pence per share)  (pence per share) 
Opening net asset 
 value                             35.29              33.50              33.50 
Revenue return                      0.21               0.21               0.41 
Capital return                      0.22               2.53               3.34 
                       -----------------  -----------------  ----------------- 
Total return                        0.43               2.74               3.75 
Dividends paid                    (1.00)             (1.00)             (2.00) 
Impact from buy-backs 
 and issue of share 
 capital                            0.01               0.02               0.04 
                       -----------------  -----------------  ----------------- 
Closing net asset 
 value                             34.73              35.26              35.29 
---------------------  -----------------  -----------------  ----------------- 
 
 
 
 
 
 
 
Shareholder return and shareholder value                  (pence per share) 
Shareholder return from launch to April 2005: 
Total dividends paid to 6 April 2005 (i)                              24.93 
Decrease in net asset value                                         (56.60) 
--------------------------------------------------------  ----------------- 
Total shareholder return to 6 April 2005                            (31.67) 
--------------------------------------------------------  ----------------- 
 
Shareholder return from April 2005 to 31 December 
 2019 (period that Albion Capital has been investment 
 manager): 
Total dividends paid                                                  33.80 
Decrease in net asset value                                          (8.67) 
--------------------------------------------------------  ----------------- 
Total shareholder return from April 2005 to 31 December 
 2019                                                                 25.13 
--------------------------------------------------------  ----------------- 
 
Shareholder value since launch: 
Total dividends paid to 31 December 2019 (i)                          58.73 
Net asset value as at 31 December 2019                                34.73 
--------------------------------------------------------  ----------------- 
Total shareholder value as at 31 December 2019                        93.46 
--------------------------------------------------------  ----------------- 
 
 
 
   Notes 
 
   (i)             Prior to 6 April 1999, venture capital trusts were able 
to add 20 per cent. to dividends and figures for the period up until 6 
April 1999 are included at the gross equivalent rate actually paid to 
shareholders. 
 
 
 
 
                                                           31 December 2019 
Total shareholder value since launch:                      (pence per share) 
--------------------------------------------------------  ------------------ 
Total dividends paid during: 
the period from launch to 6 April 2005 (prior to change 
 of manager)                                                           24.93 
the year ended 28 February 2006                                         1.00 
the period ended 30 June 2007                                           3.30 
the year ended 30 June 2008                                             2.50 
the year ended 30 June 2009                                             2.50 
the year ended 30 June 2010                                             2.50 
the year ended 30 June 2011                                             2.50 
the year ended 30 June 2012                                             2.50 
the year ended 30 June 2013                                             2.50 
the year ended 30 June 2014                                             2.50 
the year ended 30 June 2015                                             2.50 
the year ended 30 June 2016                                             2.50 
the year ended 30 June 2017                                             2.00 
the year ended 30 June 2018                                             2.00 
the year ended 30 June 2019                                             2.00 
the six months ended 31 December 2019                                   1.00 
Total dividends paid to 31 December 2019                               58.73 
Net asset value as at 31 December 2019                                 34.73 
                                                          ------------------ 
Total shareholder value as at 31 December 2019                         93.46 
--------------------------------------------------------  ------------------ 
 
 
   In addition to the dividends paid above, the Board has declared a second 
dividend for the year ending 30 June 2020 of 1 penny per share, to be 
paid on 31 March 2020 to shareholders on the register on 6 March 2020. 
 
 
 
 
Current dividend objective: 
Pence per share (per annum)                           2.00 
                                                      ---- 
Dividend yield on net asset value as at 31 December 
 2019                                                 5.8% 
                                                      ---- 
 
 
   Interim management report 
 
   Results 
 
   Crown Place VCT PLC achieved a total return of 0.43 pence per share for 
the six month period to 31 December 2019, which is a 1.2% return on 
opening net asset value per share. 
 
   Following payment of the first dividend for the year of 1 penny per 
share on 29 November 2019, the net asset value as at 31 December 2019 
was 34.73 pence per share (30 June 2019: 35.29 pence per share). 
 
   Portfolio review 
 
   During the six month period, the Company deployed GBP2.5 million into 
qualifying investments (31 December 2018: GBP1.6 million). Of this 
amount, GBP1.5 million was invested in two new portfolio companies, both 
of which are likely to require further investment as the companies 
continue to grow: 
 
 
   -- GBP779,000 into Cantab Research (trading as Speechmatics), a provider of 
      low footprint automated speech recognition software across 29 languages 
      which can be deployed in the cloud, on premise or on device; and 
 
   -- GBP724,000 into Elliptic Enterprises, a provider of Anti Money Laundering 
      technology and services to digital asset institutions. 
 
 
   Further investments were made in existing portfolio companies, most 
notably: GBP171,000 into InCrowd Sports to further develop its mobile 
apps business for professional sports clubs, GBP163,000 into Oviva to 
support their technology enabled service business in medical nutritional 
therapy, and GBP138,000 into Koru Kids to expand its current network of 
after school care into baby and toddler care. 
 
   After the period end, we invested GBP755,000 into Concirrus, a software 
provider bringing real-time behavioural data analytics to the marine and 
transport insurance industries. 
 
   There were four significant disposals in the period. Our investment in 
ELE Advanced Technologies was sold for GBP5.0 million, resulting in a 
total return of 4.75 times original cost. 
 
   As part of a reorganisation of the Radnor House School group, and the 
sale of Radnor House Twickenham in November 2019, the Company realised 
part of its investment and received proceeds of GBP4.1 million. This 
exit resulted in an average Internal Rate of Return of 19.6% per annum 
over the past nine years. The Company has retained its stake in Radnor 
House Sevenoaks, which has further capacity to grow. 
 
   The holding in Process Systems Enterprise was sold to Siemens, for 
proceeds of GBP1.4 million, resulting in a 10 times return on the 
original investment. 
 
   Our investments in the pub sector, Bravo Inns and Bravo Inns II, were 
also sold generating proceeds of GBP1.2 million combined. Over the life 
of the investment, including interest received, the Company generated a 
blended return of 1.7 times cost. 
 
   Further details on realisations and loan stock repayments can be found 
in the realisations table below. 
 
   The Company's unrealised and realised gains amounted to GBP0.8 million 
for the six months to 31 December 2019. The key movements in the period 
include: a GBP531,000 realised gain on the sale of ELE Advanced 
Technologies as referred to above, a GBP237,000 uplift in Oviva and an 
uplift of GBP134,000 in G. Network Communications, both following an 
external investment at an increased valuation. Against this, Zift 
Channel Solutions was written down by GBP183,000 as growth has been 
slower than expected. 
 
   Investment portfolio by sector 
 
   The chart at the end of this announcement illustrates the composition of 
the portfolio by industry sector as at 31 December 2019. 
 
   Shareholder consultation 
 
   As part of the special business of the Annual General Meeting held on 27 
November 2019, an ordinary resolution was proposed that increased the 
cap for the overall level of Directors' remuneration. Whilst the 
majority of shareholders supported the change, with 76.74% of the votes 
cast in favour of the resolution, the Board noted that more than 20% of 
the shareholder votes were against the resolution. 
 
   Following the Meeting, in accordance with provision 4 of the UK 
Corporate Governance Code, the Board has completed a consultation 
process with shareholders whose shareholdings represented a majority of 
votes that voted against the resolution to more fully understand the 
reasons for their opposition. 
 
   Of the total number of shares that voted against the resolution, 
shareholders representing 82% were contacted directly by the Chairman. 
Responses were received from a number of shareholders and the Board has 
taken time to carefully reflect on this feedback. 
 
   From the feedback received, the Board noted that the rationale for the 
increase, as detailed on page 34 of the Annual Report and Financial 
Statements for the year ended 30 June 2019, was not made sufficiently 
clear in the Notice of Annual General Meeting or on the proxy form. The 
Board acknowledges that the rationale was not explained as well as it 
could have been, and should have been repeated in the Notice of Annual 
General Meeting and on the proxy forms. 
 
   The Board would like to reassure Shareholders that there was no increase 
in Directors' Fees during the year, and that there is no current 
intention of increasing Directors' Fees materially in the near term, but 
the new level proposed provides extra flexibility, for example, in the 
case of an additional Board member being appointed prior to the 
retirement of an existing Director. 
 
   The Board would like to thank those shareholders who provided feedback 
on this matter and would like to emphasise that the Board is committed 
to act in the best interests of shareholders, in line with the UK 
Corporate Governance Code. 
 
   Dividends 
 
   In line with the annual dividend target for the Company of 2 pence per 
share, the first dividend for the current financial year of 1 penny per 
share was paid on 29 November 2019. A second dividend of 1 penny per 
share will be paid on 31 March 2020 to shareholders on the register on 6 
March 2020. Based on the net asset value as at 31 December 2019, an 
annual dividend of 2 pence per share equates to a 5.8% yield. 
 
 
   The Board aims to maintain this level of annualised dividend 
distribution going forward, subject to the availability of cash 
resources and distributable reserves. At 31 December 2019, the Company 
had GBP29.8 million of distributable reserves. 
 
   Dividends are paid free of tax to shareholders. Qualifying shareholders 
who elect to participate in the Dividend Reinvestment Scheme will be 
able, in respect of further dividends, to receive their dividends in the 
form of new shares rather than cash, which will entitle them to income 
tax relief at the current rate of 30% (new shares have to be held for at 
least five years to retain the tax relief). Further details of the 
Dividend Reinvestment Scheme can be found on the Company's webpage on 
the Manager's website at 
https://www.globenewswire.com/Tracker?data=4EQENyfAv-ilXByUn09DjObhkaBQYrn4Aa-2xkvkKxGUfat1Hn6QgYp8exGRMHjpEhcTDaiMSK-7dd_id5vU2ICBNfCBWVxhuQvA071kNmOAH7M6JX5dHAhdtuHMhCLK 
www.albion.capital/funds/CRWN. 
 
   Risks and uncertainties 
 
   The outlook for the UK and global economies, including any disruption 
from the departure of the UK from the EU, continues to be the key risk 
affecting the Company. Investment risk is mitigated in a number of ways, 
including our policy that the portfolio should be balanced across 
sectors and stages of investment. 
 
   Other risks and uncertainties remain unchanged and are as detailed in 
note 13 below. 
 
   Share buy-backs 
 
   It remains the Board's primary objective to maintain sufficient 
resources for investment in existing and new portfolio companies and for 
the continued payment of dividends to shareholders. The Board's policy 
is to buy back shares in the market, subject to the overall constraint 
that such purchases are in the Company's interest, and it is the Board's 
intention for such buy-backs to be in the region of a 5% discount to net 
asset value, so far as market conditions and liquidity permit. 
 
   During the period, the Company bought back and held in treasury 
1,421,000 shares at a total cost of GBP469,000, in-line with the share 
buy-back policy. 
 
   Transactions with the Manager 
 
   Details of the transactions that took place with the Manager in the 
period can be found in note 5. 
 
   Albion VCTs Prospectus Top Up Offers 2019/20 
 
   The Board was pleased to announce on 10 December 2019 that the Company 
had reached its GBP4 million limit under its offer pursuant to the 
Prospectus dated 22 October 2019, and so was closed to further 
applications. Due to the successful disposals detailed above, the Board 
elected not to exercise the over-allotment facility. The proceeds of the 
Offer will be used to provide further resources at a time when a number 
of attractive investment opportunities are being seen. 
 
   The first allotment under the Offer took place on 31 January 2020. 
Details can be found in note 10. 
 
   Board composition 
 
   As part of the Board's succession planning, and after almost eight years 
on the Board including six years as Chairman, I will retire from the 
Board in September 2020. Penny Freer, who has been on the Board since 
2014, will succeed me as Chair. The Nomination Committee has commenced a 
process to recruit a new Non-Executive Director to join the Board ahead 
of my retirement. 
 
   Fraud warning 
 
   We note over recent months an increase in the number of shareholders 
being contacted in connection with sophisticated but fraudulent 
financial scams. This is often by a phone call or an email which 
normally originates from outside of the UK, often claiming or appearing 
to come from a corporate finance firm and typically offering to buy your 
VCT shares at an inflated price. If you are contacted, we recommend that 
you do not respond with any personal information and say you are not 
interested. 
 
   The Manager maintains a page on their website in relation to fraud 
advice at www.albion.capital/investor-centre/fraud-advice. 
 
   If you are in any doubt, we recommend that you seek financial advice 
before taking any action. You can also call Shareholder Relations on 020 
7601 1850, or email info@albion.capital 
https://www.globenewswire.com/Tracker?data=1XhzWbyIFC5P5NrgS63R-nrN9X0rMnakb33D-PHGE0H0OGCsKDeFzEoEWHtJeZE_Sw574IQ-y03jzCHcegymYgtUQRYnpOvODOumv1C-yvY= 
, if you wish to check whether any claims made are genuine. 
 
   Outlook 
 
   The Company yielded double digit total returns in each of the last three 
financial years. Whilst the portfolio has seen a more modest gain during 
the six months to 31 December 2019, the Board is encouraged by the 
successful exits of both technology and asset backed investments during 
the period. The performance and prospects of a number of companies 
within the investment portfolio, as well as the quality of the new 
investments being made, gives us cause to be optimistic about the long 
term prospects of the Company. Whilst there may be increased volatility 
within the portfolio over the coming years, we remain confident in the 
fundamentals of the investments within our portfolio to continue to grow 
shareholder value over time. 
 
   Richard Huntingford 
 
   Chairman 
 
   20 February 2020 
 
   Responsibility statement 
 
   The Directors, Richard Huntingford, James Agnew, Penny Freer and Pam 
Garside, are responsible for preparing the Half-yearly Financial Report. 
In preparing these condensed Financial Statements for the period to 31 
December 2019 we, the Directors of the Company, confirm that to the best 
of our knowledge: 
 
   (a) the condensed set of Financial Statements, which has been prepared 
in accordance with Financial Reporting Standard 104 "Interim Financial 
Reporting", gives a true and fair view of the assets, liabilities, 
financial position and profit and loss of the Company as required by DTR 
4.2.4R; 
 
   (b) the Interim management report includes a fair review of the 
information required by DTR 4.2.7R (indication of important events 
during the first six months and description of principal risks and 
uncertainties for the remaining six months of the year); and 
 
   (c) the Interim management report includes a fair review of the 
information required by DTR 4.2.8R (disclosure of related parties' 
transactions and changes therein). 
 
   This Half-yearly Financial Report has not been audited or reviewed by 
the Auditor. 
 
   For and on behalf of the Board 
 
   Richard Huntingford 
 
   Chairman 
 
   20 February 2020 
 
   Portfolio of investments 
 
 
 
 
                                                                                                                                  As at 31 December 2019    As at 30 June 2019 
                                                                                                                                        (unaudited)              (audited) 
                                                                                                                                                                                 ------------------------------- 
                                                                                                                           % 
                                                                                                                         voting    Cost         Value        Cost       Value    Change in value for the period* 
Portfolio company                                      Nature of business                                                rights   GBP'000      GBP'000      GBP'000    GBP'000               GBP'000 
-----------------------------------------------------  ---------------------------------------------------------------  -------             -------------             ---------  ------------------------------- 
                                                       Owner and operator of a 66 bed care home in Shinfield, 
Shinfield Lodge Care Limited                            Berkshire                                                          11.8      2,140          4,271      2,140      4,216                               55 
                                                       Owner and operator of a 2 MW hydro-power scheme in 
Chonais River Hydro Limited                             the Scottish Highlands                                             14.0      1,549          3,253      1,549      3,255                              (2) 
Radnor House School (TopCo) Limited                    Independent school for children aged 5-18                            8.7      1,592          2,778      2,665      6,770                               45 
                                                       Owner and operator of a 75 bed care home in Cumnor 
Active Lives Care Limited                               Hill, Oxfordshire                                                   7.5      1,620          2,767      1,620      2,771                              (4) 
Proveca Limited                                        Reformulation of paediatric medicines                                6.1        974          2,380        974      2,317                               63 
                                                       Owner and operator of a 60 bed care home in Hillingdon, 
Ryefield Court Care Limited                             Middlesex                                                           7.7      1,275          2,258      1,275      2,239                               19 
Quantexa Limited                                       Network analytics platform to detect financial crime                 1.7        438          1,816        438      1,816                                - 
                                                       Owner and operator of a 1 MW hydro-power scheme in 
Gharagain River Hydro Limited                           the Scottish Highlands                                             15.0      1,116          1,670      1,116      1,650                               20 
Mirada Medical Limited                                 Developer of medical imaging software                                5.8        511          1,531        511      1,531                                - 
Beddlestead Limited                                    Developer and operator of a dedicated wedding venue                  8.2      1,060          1,068      1,060      1,066                                2 
                                                       Ultra-fast fibre optic broadband provider in central 
G. Network Communications Limited                       London                                                              1.8        186          1,009        580      1,269                              134 
                                                       A technology enabled service business in medical nutritional 
Oviva AG                                                therapy (MNT)                                                       2.1        598            849        435        449                              237 
Egress Software Technologies Limited                   Encrypted email and file transfer service provider                   0.9        306            846        306        846                                - 
                                                       Owner and operator of photovoltaic systems on domestic 
The Street by Street Solar Programme Limited            properties                                                          4.4        461            845        461        812                               33 
The Evewell (Harley Street) Limited                    Operator of a women's health centre focusing on fertility            6.2        824            824        778        778                                - 
                                                       Provider of low footprint automated speech recognition 
Cantab Research Limited (T/A Speechmatics)              software across 29 languages                                        1.9        779            779          -          -                                - 
                                                       Provider of Anti Money Laundering services to digital 
Elliptic Enterprises Limited                            asset institutions                                                  0.9        724            724          -          -                                - 
Convertr Media Limited                                 Digital lead generation software                                     4.3        680            695        664        676                                3 
                                                       Generator of renewable energy from roof top solar 
Regenerco Renewable Energy Limited                      installations                                                       3.4        344            582        344        558                               24 
                                                       Owner and operator of community scale wind energy 
Alto Prodotto Wind Limited                              projects                                                            4.1        336            564        345        577                                1 
MPP Global Solutions Limited                           Provider of a digital subscription management platform               1.7        550            550        550        550                                - 
Koru Kids Limited                                      Online marketplace connecting parents and nannies                    1.6        338            527        200        389                                - 
                                                       Developer of software to improve decision making through 
Avora Limited                                           augmented analytics & machine learning                              2.8        510            510        510        510                                - 
MHS 1 Limited                                          Education                                                            6.9        481            481        481        480                                1 
Black Swan Data Limited                                Data analysis that supports corporate decision making                1.3        477            477        454        454                                - 
Panaseer Limited                                       Provider of cyber security services                                  1.5        342            471        253        351                               31 
DySIS Medical Limited                                  Medical devices for the detection of cervical cancer                 1.9      1,038            441      1,038        536                             (95) 
SBD Automotive Limited (previously Secured by Design 
 Limited)                                              Automotive technology research and consultancy provider              1.5        220            428        220        469                             (41) 
                                                       Provider of a platform for collecting data from pharmaceutical 
MyMeds&Me Limited                                       adverse events                                                      4.6        440            416        440        416                                - 
InCrowd Sports Limited                                 Developer of mobile apps for professional sports clubs               2.5        318            410        147        161                               78 
                                                       Provider of a technology solution for the management 
Locum's Nest Limited                                    of locum doctors for the NHS                                        4.6        400            380        400        424                             (44) 
Phrasee Limited                                        AI platform that generates optimised marketing campaigns             1.7        356            356        356        356                                - 
                                                       Online community connecting people affected by rare 
ePatient Network Limited (T/A Raremark)                 diseases                                                            2.4        230            310        115         73                              122 
                                                       Provider of a customer service platform powered by 
Limitless Technology Limited                            the crowd and machine learning technology                           1.8        280            280        280        280                                - 
                                                       Provider of talent management software to mid market 
Clear Review Limited                                    enterprises                                                         1.8        231            231        231        231                                - 
                                                       Development of biopharmaceuticals through the application 
Arecor Limited                                          of a formulation technology platform                                1.1        210            210        210        210                                - 
Oxsensis Limited                                       Developer and producer of high temperature sensors                   1.7        274            210        274        210                                - 
                                                       Provider of an online platform delivering family centric 
Healios Limited                                         psychological care                                                  0.7        203            203         75         75                                - 
                                                       Owner and operator of photovoltaic systems on domestic 
AVESI Limited                                           properties                                                          3.8        123            184        123        177                                7 
Zift Channel Solutions Inc.                            Business collaboration and communication solutions                   0.6        321            183        321        366                            (183) 
Sandcroft Avenue Limited (T/A Hussle)                  A provider of flexible access to gyms                                0.9        171            169        159        151                                6 
                                                       Software and services for non-interventional clinical 
Cisiv Limited                                           trials                                                              3.1        278            160        278        267                            (107) 
                                                       A patient engagement and data capture platform for 
uMotif Limited                                          use in research                                                     0.9        210            152        140         98                             (16) 
OmPrompt Holdings Limited                              A provider of process automation software                            1.6        153            148        153        148                                - 
                                                       Refurbisher and manufacturer of MEMS and semiconductor 
memsstar Limited                                        fabrication equipment                                               3.0         77            126         97        169                             (23) 
                                                       Operator of a Holiday Inn Express hotel at Stansted 
Kew Green VCT (Stansted) Limited                        Airport                                                             2.0         22            121         22        121                                - 
                                                       A secure mobile communication and collaboration platform 
Forward Clinical Limited (T/A Pando)                    in healthcare                                                       1.5        184            108        160        160                             (76) 
Abcodia Limited                                        Validation and discovery of serum biomarkers                         1.7        304            107        304        107                                - 
                                                       Provider of automated software testing and an enhanced 
Imandra Inc.                                            learning experience for artificial neural networks                  1.1        106            106        106        106                                - 
Greenenerco Limited                                    Owns & operates a 500kW wind project                                 1.9         57            100         59        102                                - 
Innovation Broking Group Limited                       Commercial insurance broker                                          2.7         27             60         27         59                                1 
Aridhia Informatics Limited                            Healthcare informatics and analysis provider                         2.3        442             58        442         94                             (36) 
                                                       A designer and manufacturer of radiation detection 
Symetrica Limited                                       equipment                                                           0.2         43             40         43         43                              (3) 
Mi-Pay Group PLC                                       Provider of mobile payment services                                  3.0        713             20        713        130                            (110) 
Palm Tree Technology Limited                           Software company                                                     0.2        102             12        102         12                                - 
Avanti Communications Group Limited                    Supplier of satellite communications                                 0.1        136              1        136          1                                - 
Other holdings                                                                                                                         486            509        486        507                                2 
----------------------------------------------------------------------------------------------------------------------  -------  ---------  -------------  ---------  ---------  ------------------------------- 
Total fixed asset investments                                                                                                       28,366         40,764     27,366     42,589                              144 
-------------------------------------------------------------------------------------------------------------------------------  ---------  -------------  ---------  ---------  ------------------------------- 
 
 
   * As adjusted for additions and disposals between the two accounting 
periods 
 
   The total comparative cost and valuations for 30 June 2019 do not agree 
to the Annual Report and Financial Statements for the year ended 30 June 
2019 as the above list does not include brought forward investments that 
were fully disposed of in the period. 
 
 
 
 
                             Opening                 Total      Gain/(loss) on 
Realisations in              carrying  Disposal     realised        opening 
the period to 31    Cost      value     proceeds   gain/(loss)       value 
December 2019      GBP'000   GBP'000    GBP'000      GBP'000        GBP'000 
----------------  --------  ---------  ---------  ------------  -------------- 
Disposals: 
----------------  --------  ---------  ---------  ------------  -------------- 
ELE Advanced 
 Technologies 
 Limited             1,050      4,453      4,984         3,934             531 
Radnor House 
 School (TopCo) 
 Limited             1,073      4,036      4,116         3,043              80 
Process Systems 
 Enterprise 
 Limited               138      1,372      1,413         1,275              41 
Bravo Inns II 
 Limited               595        871        920           325              49 
Augean PLC             593        407        368         (225)            (39) 
Bravo Inns 
 Limited               306        251        235          (71)            (16) 
 
Loan stock 
repayments and 
other: 
----------------  --------  ---------  ---------  ------------  -------------- 
G. Network 
 Communications 
 Limited               394        394        394             -               - 
Black Swan Data 
 Limited               128        128        151            23              23 
memsstar Limited        20         20         20             -               - 
Alto Prodotto 
 Wind Limited            8         14         14             6               - 
Greenenerco 
 Limited                 2          3          3             1               - 
Escrow 
 adjustments**           -          -         29            29              29 
 
Total fixed 
 asset 
 investment 
 realisations        4,307     11,949     12,647         8,340             698 
----------------  --------  ---------  ---------  ------------  -------------- 
 
 
   ** Fair value movements on deferred consideration from previously 
disposed investments. 
 
 
 
 
Total change in value of investments                     144 
Movement in loan stock accrued interest                    2 
                                                         --- 
Unrealised gains sub-total                               146 
Realised gains in current period                         698 
Total gains on investments as per condensed income 
 statement                                               844 
-------------------------------------------------------  --- 
 
 
   Condensed income statement 
 
 
 
 
                                                                   Unaudited                  Unaudited          Audited 
                                                               six months ended           six months ended              year ended 
                                                                31 December 2019           31 December 2018             30 June 2019 
                                                           Revenue  Capital   Total   Revenue  Capital   Total   Revenue  Capital   Total 
                                                     Note  GBP'000  GBP'000  GBP'000  GBP'000  GBP'000  GBP'000  GBP'000  GBP'000  GBP'000 
---------------------------------------------------  ----  -------  -------  -------  -------  -------  -------  -------  -------  ------- 
 
 
Gains on investments                                    3        -      844      844        -    4,547    4,547        -    6,475    6,475 
Investment income                                       4      699        -      699      637        -      637    1,285        -    1,285 
 
Investment management fees                              5    (144)    (431)    (575)    (125)    (376)    (501)    (260)    (780)  (1,040) 
Other expenses                                               (167)        -    (167)    (164)        -    (164)    (328)        -    (328) 
                                                           -------  -------  -------  -------  -------  -------  -------  -------  ------- 
Profit on ordinary activities before tax                       388      413      801      348    4,171    4,519      697    5,695    6,392 
Tax on ordinary activities                                       -        -        -        -        -        -        -        -        - 
                                                           -------  -------  -------  -------  -------  -------  -------  -------  ------- 
Profit and total comprehensive income attributable 
 to shareholders                                               388      413      801      348    4,171    4,519      697    5,695    6,392 
                                                           -------  -------  -------  -------  -------  -------  -------  -------  ------- 
Basic and diluted earnings per Ordinary share 
 (pence)*                                               7     0.21     0.22     0.43     0.21     2.53     2.74     0.41     3.34     3.75 
                                                           -------  -------  -------  -------  -------  -------  -------  -------  ------- 
 
 
   * adjusting for treasury shares 
 
   Comparative figures have been extracted from the unaudited Half-yearly 
Financial Report for the six months ended 31 December 2018 and the 
audited statutory accounts for the year ended 30 June 2019. 
 
   The accompanying notes form an integral part of this Half-yearly 
Financial Report. 
 
   The total column of this condensed income statement represents the 
profit and loss account of the Company. The supplementary revenue and 
capital columns are prepared under guidance published by The Association 
of Investment Companies. 
 
   Condensed balance sheet 
 
 
 
 
                                 Unaudited         Unaudited        Audited 
                              31 December 2019  31 December 2018  30 June 2019 
                        Note      GBP'000           GBP'000         GBP'000 
----------------------  ----  ----------------  ----------------  ------------ 
 
 
Fixed asset 
 investments                            40,764            48,601        49,943 
 
Current assets 
Trade and other 
 receivables less than 
 one year                                  164               249           359 
Cash and cash 
 equivalents                            24,183             9,596        16,083 
                              ----------------  ----------------  ------------ 
                                        24,347             9,845        16,442 
 
Total assets                            65,111            58,446        66,385 
 
Payables: amounts 
falling due within one 
year 
Trade and other 
 payables less than 
 one year                                (360)             (327)         (390) 
 
Total assets less 
 current liabilities                    64,751            58,119        65,995 
                              ----------------  ----------------  ------------ 
 
Equity attributable to 
equity holders 
Called up share 
 capital                   8             2,080             1,837         2,072 
Share premium                            9,338             1,230         9,061 
Unrealised capital 
 reserve                                12,260            17,357        19,756 
Realised capital 
 reserve                                 6,052             (982)       (1,857) 
Other distributable 
 reserve                                35,021            38,677        36,963 
                              ----------------  ----------------  ------------ 
Total equity 
 shareholders' funds                    64,751            58,119        65,995 
                              ----------------  ----------------  ------------ 
Basic and diluted net 
 asset value per share 
 (pence)*                                34.73             35.26         35.29 
                              ----------------  ----------------  ------------ 
 
 
   * excluding treasury shares 
 
   Comparative figures have been extracted from the unaudited Half-yearly 
Financial Report for the six months ended 31 December 2018 and the 
audited statutory accounts for the year ended 30 June 2019. 
 
   The accompanying notes form an integral part of this Half-yearly 
Financial Report. 
 
   These Financial Statements were approved by the Board of Directors, and 
authorised for issue on 20 February 2020 and were signed on its behalf 
by 
 
   Richard Huntingford 
 
   Chairman 
 
   Company number 03495287 
 
   Condensed statement of changes in equity 
 
 
 
 
                                                                                  Unrealised  Realised 
                                                          Ordinary       Share      capital    capital   Other distributable 
                                                        share capital    premium    reserve    reserve*        reserve*        Total 
                                                           GBP'000       GBP'000    GBP'000    GBP'000         GBP'000         GBP'000 
----------------------------------------------------- 
As at 1 July 2019                                               2,072      9,061      19,756    (1,857)               36,963    65,995 
Profit and total comprehensive income                               -          -         146        267                  388       801 
Transfer of previously unrealised gains on disposals 
 of investments                                                     -          -     (7,642)      7,642                    -         - 
Dividends paid                                                      -          -           -          -              (1,861)   (1,861) 
Purchase of shares for treasury (including costs)                   -          -           -          -                (469)     (469) 
Issue of equity                                                     9        292           -          -                    -       301 
Cost of issue of equity                                             -       (16)           -          -                    -      (16) 
                                                       --------------  ---------  ----------  ---------  -------------------  -------- 
As at 31 December 2019                                          2,080      9,338      12,260      6,052               35,021    64,751 
-----------------------------------------------------  --------------  ---------  ----------  ---------  -------------------  -------- 
 
 As at 1 July 2018                                              1,829        974      12,973      (769)               40,407    55,414 
Profit/(loss) and total comprehensive income                        -          -       4,520      (349)                  348     4,519 
Transfer of previously unrealised gains on disposals 
 of investments                                                     -          -       (136)        136                    -         - 
Dividends paid                                                      -          -           -          -              (1,649)   (1,649) 
Purchase of shares for treasury (including costs)                   -          -           -          -                (429)     (429) 
Issue of equity                                                     8        258           -          -                    -       266 
Cost of issue of equity                                             -        (2)           -          -                    -       (2) 
                                                       --------------  ---------  ----------  ---------  -------------------  -------- 
As at 31 December 2018                                          1,837      1,230      17,357      (982)               38,677    58,119 
                                                       --------------  ---------  ----------  ---------  -------------------  -------- 
As at 1 July 2018                                               1,829        974      12,973      (769)               40,407    55,414 
Profit/(loss) and total comprehensive income                        -          -       5,929      (234)                  697     6,392 
Transfer of previously unrealised losses on disposal 
 of investments                                                     -          -         854      (854)                    -         - 
Dividends paid                                                      -          -           -          -              (3,280)   (3,280) 
Purchase of shares for treasury (including costs)                   -          -           -          -                (861)     (861) 
Issue of equity                                                   243      8,277           -          -                    -     8,520 
Cost of issue of equity                                             -      (190)           -          -                    -     (190) 
As at 30 June 2019                                              2,072      9,061      19,756    (1,857)               36,963    65,995 
-----------------------------------------------------  --------------  ---------  ----------  ---------  -------------------  -------- 
 
 
 
   * Included within these reserves is an amount of GBP29,836,000 (31 
December 2018: GBP19,712,000; 30 June 2019: GBP17,123,000) which is 
considered distributable. In time, a further GBP11,237,000 will become 
distributable. 
 
   Condensed statement of cash flows 
 
 
 
 
                               Unaudited                           Audited 
                            six months ended      Unaudited       year ended 
                              31 December      six months ended    30 June 
                                  2019         31 December 2018      2019 
                                GBP'000            GBP'000         GBP'000 
------------------------ 
Cash flow from operating 
activities 
Loan stock income 
 received                                646                619        1,378 
Deposit interest received                 45                 19           45 
Dividend income received                   9                 15           61 
Investment management 
 fees paid                             (578)              (486)        (993) 
Other cash payments                    (194)              (181)        (316) 
Corporation tax paid                       -                  -            - 
                           -----------------  -----------------  ----------- 
Net cash flow from 
 operating activities                   (72)               (14)          175 
                           -----------------  -----------------  ----------- 
 
Cash flow from investing 
activities 
Purchase of fixed asset 
 investments                         (2,475)            (1,590)      (3,536) 
Disposal of fixed asset 
 investments                          12,676                430        2,686 
Net cash flow from 
 investing activities                 10,201            (1,160)        (850) 
                           -----------------  -----------------  ----------- 
 
Cash flow from financing 
activities 
Issue of share capital                     -                  -        7,802 
Cost of issue of equity                 (15)                  -          (3) 
Equity dividends paid                (1,545)            (1,369)      (2,749) 
Purchase of own shares 
 for treasury (including 
 costs)                                (469)              (465)        (896) 
Net cash flow from 
 financing activities                (2,029)            (1,834)        4,154 
 
Increase/(decrease) in 
 cash and cash 
 equivalents                           8,100            (3,008)        3,479 
Cash and cash equivalents 
 at the start of the 
 period                               16,083             12,604       12,604 
                           -----------------  -----------------  ----------- 
Cash and cash equivalents 
 at the end of the 
 period                               24,183              9,596       16,083 
                           -----------------  -----------------  ----------- 
 
Cash and cash 
equivalents comprise: 
Cash at bank                          24,183              9,596       16,083 
Cash equivalents                           -                  -            - 
                           -----------------  -----------------  ----------- 
Total cash and cash 
 equivalents                          24,183              9,596       16,083 
                           -----------------  -----------------  ----------- 
 
 
 
   Notes to the unaudited condensed Financial Statements 
 
   1.   Basis of preparation 
 
   The condensed Financial Statements have been prepared in accordance with 
the historical cost convention, modified to include the revaluation of 
investments, in accordance with applicable United Kingdom law and 
accounting standards, including Financial Reporting Standard 102 ("FRS 
102"), Financial Reporting Standard 104 -- Interim Financial Reporting 
("FRS 104"), and with the Statement of Recommended Practice "Financial 
Statements of Investment Trust Companies and Venture Capital Trusts" 
("SORP") issued by The Association of Investment Companies ("AIC"). 
 
   The preparation of the Financial Statements requires management to make 
judgements and estimates that affect the application of policies and 
reported amounts of assets, liabilities, income and expenses. The most 
critical estimates and judgements relate to the determination of 
carrying value of investments at fair value through profit and loss 
("FVTPL"). The Company values investments by following the International 
Private Equity and Venture Capital Valuation ("IPEV") Guidelines and 
further detail on the valuation techniques used are outlined in note 2 
below. 
 
   The Half-yearly Financial Report has not been audited, nor has it been 
reviewed by the auditor pursuant to the FRC's guidance on Review of 
interim financial information. 
 
   Company information can be found on page 2 of the full Half-yearly 
Financial Report. 
 
   2.   Accounting policies 
 
   Fixed asset investments 
 
   The Company's business is investing in financial assets with a view to 
profiting from their total return in the form of income and capital 
growth. This portfolio of financial assets is managed and its 
performance evaluated on a fair value basis, in accordance with a 
documented investment policy, and information about the portfolio is 
provided internally on that basis to the Board. 
 
   In accordance with the requirements of FRS 102, those undertakings in 
which the Company holds more than 20 per cent. of the equity as part of 
an investment portfolio are not accounted for using the equity method. 
In these circumstances the investment is measured at FVTPL. 
 
   Upon initial recognition (using trade date accounting) investments, 
including loan stock, are classified by the Company as FVTPL and are 
included at their initial fair value, which is cost (excluding expenses 
incidental to the acquisition which are written off to the income 
statement). 
 
   Subsequently, the investments are valued at 'fair value', which is 
measured as follows: 
 
 
   -- Investments listed on recognised exchanges are valued at their bid prices 
      at the end of the accounting period or otherwise at fair value based on 
      published price quotations; 
 
   -- Unquoted investments, where there is not an active market, are valued 
      using an appropriate valuation technique in accordance with the IPEV 
      Guidelines. Indicators of fair value are derived using established 
      methodologies including earnings multiples, revenue multiples, the level 
      of third party offers received, cost or prices of recent investment 
      rounds, net assets and industry valuation benchmarks. Where price of 
      recent investment is used as a starting point for estimating fair value 
      at subsequent measurement dates, this has been benchmarked using an 
      appropriate valuation technique permitted by the IPEV guidelines. 
 
   -- In situations where cost or price of recent investment is used, 
      consideration is given to the circumstances of the portfolio company 
      since that date in determining fair value. This includes consideration of 
      whether there is any evidence of deterioration or strong definable 
      evidence of an increase in value. In the absence of these indicators, the 
      investment in question is valued at the amount reported at the previous 
      reporting date. Examples of events or changes that could indicate a 
      diminution include: 
 
          -- the performance and/or prospects of the underlying business are 
             significantly below the expectations on which the investment was 
             based; 
 
          -- a significant adverse change either in the portfolio company's 
             business or in the technological, market, economic, legal or 
             regulatory environment in which the business operates; or 
 
          -- market conditions have deteriorated, which may be indicated by a 
             fall in the share prices of quoted businesses operating in the 
             same or related sectors. 
 
 
   Investments are recognised as financial assets on legal completion of 
the investment contract and are de-recognised on legal completion of the 
sale of an investment. 
 
   Dividend income is not recognised as part of the fair value movement of 
an investment, but is recognised separately as investment income through 
the other distributable reserve when a share becomes ex-dividend. 
 
   Current assets and payables 
 
   Receivables, payables and cash are carried at amortised cost, in 
accordance with FRS 102. There are no financial liabilities other than 
payables. 
 
   Investment income 
 
   Equity income 
 
   Dividend income is included in revenue when the investment is quoted 
ex-dividend. 
 
   Unquoted loan stock income 
 
   Fixed returns on non-equity shares and debt securities are recognised 
when the Company's right to receive payment and expect settlement is 
established. Where interest is rolled up and/or payable at redemption 
then it is recognised as income unless there is reasonable doubt as to 
its receipt. 
 
   Bank interest income 
 
   Interest income is recognised on an accruals basis using the rate of 
interest agreed with the bank. 
 
   Investment management fees, performance incentive fees and other 
expenses 
 
   All expenses have been accounted for on an accruals basis. Expenses are 
charged through the revenue column of the condensed income statement, 
except for management fees and performance incentive fees which are 
allocated in part to the capital column of the Income statement, to the 
extent that these relate to the maintenance or enhancement in the value 
of the investments and in line with the Board's expectation that over 
the long term 75 per cent. of the Company's investment returns will be 
in the form of capital gains. 
 
   Taxation 
 
   Taxation is applied on a current basis in accordance with FRS 102. 
Current tax is tax payable (refundable) in respect of the taxable profit 
(tax loss) for the current period or past reporting periods using the 
tax rates and laws that have been enacted or substantively enacted at 
the financial reporting date. Taxation associated with capital expenses 
is applied in accordance with the SORP. 
 
   Deferred tax is provided in full on all timing differences at the 
reporting date. Timing differences are differences between taxable 
profits and total comprehensive income as stated in the Financial 
Statements that arise from the inclusion of income and expenses in tax 
assessments in periods different from those in which they are recognised 
in the Financial Statements. As a VCT the Company has an exemption from 
tax on capital gains. The Company intends to continue meeting the 
conditions required to obtain approval as a VCT in the foreseeable 
future. The Company therefore, should have no material deferred tax 
timing differences arising in respect of the revaluation or disposal of 
investments and the Company has not provided for any deferred tax. 
 
   Reserves 
 
   Share premium 
 
   This reserve accounts for the difference between the price paid for 
shares and the nominal value of the shares, less issue costs. 
 
   Capital redemption reserve 
 
   This reserve accounts for amounts by which the issued share capital is 
diminished through the repurchase and cancellation of the Company's own 
shares. 
 
   Unrealised capital reserve 
 
   Increases and decreases in the valuation of investments held at the year 
end against cost, are included in this reserve. 
 
   Realised capital reserve 
 
   The following are disclosed in this reserve: 
 
 
   -- gains and losses compared to cost on the realisation of investments, or 
      permanent diminution in value; 
 
   -- expenses, together with the related taxation effect, charged in 
      accordance with the above policies; and 
 
   -- dividends paid to equity holders where paid out by capital. 
 
   Other distributable reserve 
 
   The special reserve, treasury share reserve and the revenue reserve were 
combined in 2012 to form a single reserve named other distributable 
reserve. 
 
   This reserve accounts for movements from the revenue column of the 
Income statement, the payment of dividends, the buy-back of shares and 
other non-capital realised movements. 
 
   Dividends 
 
   Dividends by the Company are accounted for in the period in which the 
dividend is paid or approved at the Annual General Meeting. 
 
   Segmental reporting 
 
   The Directors are of the opinion that the Company is engaged in a single 
operating segment of business, being investment in smaller companies 
principally based in the UK. 
 
   3.   Gains on investments 
 
 
 
 
                               Unaudited          Unaudited         Audited 
                            six months ended   six months ended    year ended 
                            31 December 2019   31 December 2018   30 June 2019 
                                GBP'000            GBP'000          GBP'000 
------------------------- 
Unrealised gains on fixed 
 asset investments                       146              4,520          5,929 
Realised gains on fixed 
 asset investments                       698                 27            546 
                           -----------------  -----------------  ------------- 
                                         844              4,547          6,475 
                           -----------------  -----------------  ------------- 
 
 
   4.   Investment income 
 
 
 
 
                               Unaudited          Unaudited         Audited 
                            six months ended   six months ended    year ended 
                            31 December 2019   31 December 2018   30 June 2019 
                                GBP'000            GBP'000          GBP'000 
------------------------- 
Loan stock interest and 
 other fixed returns                     644                602          1,179 
UK dividend income                         9                 15             61 
Bank deposit interest                     46                 20             45 
                           -----------------  -----------------  ------------- 
                                         699                637          1,285 
                           -----------------  -----------------  ------------- 
 
 
   5.   Investment management fees 
 
 
 
 
                      Unaudited                     Unaudited            Audited 
                   six months ended              six months ended         year ended 
                   31 December 2019              31 December 2018         30 June 2019 
             Revenue   Capital    Total    Revenue   Capital    Total    Revenue   Capital    Total 
              GBP'000   GBP'000   GBP'000   GBP'000   GBP'000   GBP'000   GBP'000   GBP'000   GBP'000 
-----------  --------  --------  --------  --------  --------  --------  --------  --------  -------- 
Investment 
 management 
 fee              144       431       575       125       376       501       260       780     1,040 
             --------  --------  --------  --------  --------  --------  --------  --------  -------- 
 
 
   Further details of the management agreement under which the investment 
management fee is paid are given on page 13 of the Strategic report in 
the Annual Report and Financial Statements for the year ended 30 June 
2019. 
 
   During the period, services of a total value of GBP600,000 (31 December 
2018: GBP526,000; 30 June 2019: GBP1,090,000) were purchased by the 
Company from Albion Capital Group LLP; comprising GBP575,000 management 
fee and GBP25,000 administration fee. At the financial period end, the 
amount due to Albion Capital Group LLP disclosed as payables was 
GBP297,000 (administration fee accrual GBP12,500, management fee accrual 
GBP284,500) (31 December 2018: GBP269,000; 30 June 2019: GBP300,500). 
 
   Albion Capital Group LLP is, from time to time, eligible to receive 
arrangement fees and monitoring fees from portfolio companies. During 
the period to 31 December 2019, fees of GBP74,000 attributable to the 
investments of the Company were received pursuant to these arrangements 
(31 December 2018: GBP72,000; 30 June 2019: GBP167,000). 
 
   Albion Capital Group LLP, its partners and staff hold 1,090,631 Ordinary 
shares in the Company. 
 
   6.   Dividends 
 
 
 
 
                                                              Unaudited          Unaudited         Audited 
                                                           six months ended   six months ended    year ended 
                                                           31 December 2019   31 December 2018   30 June 2019 
                                                               GBP'000            GBP'000          GBP'000 
-------------------------------------------------------- 
First dividend of 1 penny per share paid on 30 November 
 2018                                                                     -              1,649          1,649 
Second dividend of 1 penny per share paid on 29 March 
 2019                                                                     -                  -          1,646 
First dividend of 1 penny per share paid on 29 November 
 2019                                                                 1,861                  -              - 
Unclaimed dividends                                                       -                  -           (15) 
                                                          -----------------  -----------------  ------------- 
                                                                      1,861              1,649          3,280 
                                                          -----------------  -----------------  ------------- 
 
 
   In addition, the Board has declared a second dividend of 1 penny per 
share for the year ending 30 June 2020. This will be paid on 31 March 
2020 to shareholders on the register on 6 March 2020. This is expected 
to amount to approximately GBP1,971,000. 
 
   7.   Basic and diluted return per share 
 
 
 
 
 
 
                                                               Unaudited                Unaudited         Audited 
                                                            six months ended         six months ended      year ended 
                                                            31 December 2019         31 December 2018      30 June 2019 
                                                        Revenue  Capital  Total  Revenue  Capital  Total  Revenue  Capital  Total 
------------------------------------------------------  -------  -------  -----  -------  -------  -----  -------  -------  ----- 
Return attributable to equity shares (GBP'000)              388      413    801      348    4,171  4,519      697    5,695  6,392 
                                                        -------  -------  -----  -------  -------  -----  -------  -------  ----- 
Weighted average 
 shares in issue 
 (adjusting for treasury 
 shares)                                                      186,644,811              165,106,141              170,478,118 
                                                        -----------------------  -----------------------  ----------------------- 
Return attributable per Ordinary share (pence) (basic 
 and diluted)                                              0.21     0.22   0.43     0.21     2.53   2.74     0.41     3.34   3.75 
                                                        -------  -------  -----  -------  -------  -----  -------  -------  ----- 
 
 
 
 
   The return per share has been calculated after adjusting for treasury 
shares of 21,589,410 (31 December 2018: 18,840,410; 30 June 2019: 
20,168,410). 
 
   There are no convertible instruments, derivatives or contingent share 
agreements in issue, and therefore no dilution affecting the return per 
share. The basic return per share is therefore the same as the diluted 
return per share. 
 
   8.   Ordinary share capital 
 
 
 
 
Allotted, called up and fully paid Ordinary shares       Unaudited          Unaudited         Audited 
 of 1 penny each                                      31 December 2019   31 December 2018   30 June 2019 
--------------------------------------------------- 
Number of shares                                           208,035,211        183,657,792    207,170,647 
Nominal value of allotted shares (GBP'000)                       2,080              1,837          2,072 
Voting rights (number of shares net of treasury 
 shares)                                                   186,445,801        164,817,382    187,002,237 
 
 
   During the period to 31 December 2019 the Company purchased 1,421,000 
Ordinary shares (nominal value GBP14,000) for treasury at a cost of 
GBP469,000. The total number of Ordinary shares held in treasury as at 
31 December 2019 was 21,589,410 (31 December 2018: 18,840,410; 30 June 
2019: 20,168,410) representing 10.4 per cent. of the Ordinary shares in 
issue as at 31 December 2019. 
 
   Under the terms of the Dividend Reinvestment Scheme Circular dated 26 
February 2009, the following new Ordinary shares of nominal value 1 
penny per share were allotted during the period: 
 
 
 
 
              Number 
                of 
 Allotment    shares   Aggregate nominal value of shares     Issue price      Net invested  Opening market price on allotment date 
 date        allotted              (GBP'000)               (pence per share)    (GBP'000)              (pence per share) 
29 November 
 2019         864,564                                  9               34.82           285                                   32.70 
 
 
   9.   Contingencies and guarantees 
 
   As at 31 December 2019 the Company had no financial commitments in 
respect of investments (31 December 2018: GBPnil; 30 June 2019: GBPnil). 
 
   There are no external contingencies or guarantees of the Company as at 
31 December 2019 (31 December 2018: GBPnil; 30 June 2019: GBPnil). 
 
   10. Post balance sheet events 
 
   Since 31 December 2019, the Company has completed the following material 
transaction: 
 
   --Investment of GBP755,000 in a new portfolio company, Concirrus Limited, 
a  software provider bringing real-time behavioural data analytics to 
the marine and transport insurance industries. 
 
   The following new Ordinary shares of nominal value 1 penny each were 
allotted under the Albion VCTs Prospectus Top Up Offers 2019/20 after 31 
December 2019: 
 
 
 
 
                        Aggregate    Issue 
            Number of    nominal     price          Net        Opening market 
Date of       shares    value of     (pence    consideration      price on 
allotment    allotted    shares       per        received      allotment date 
                         GBP'000     share)       GBP'000     (pence per share) 
----------  ----------  ---------  ----------  -------------  ----------------- 
31 January 
      2020   4,051,167         41       35.40          1,413              32.70 
31 January 
      2020     904,613          9       35.60            316              32.70 
31 January 
      2020   5,684,033         57       35.80          1,983              32.70 
            10,639,813                                 3,712 
            ----------                         ------------- 
 
 
   11. Related party transactions 
 
   Other than transactions with the Manager as disclosed in note 5, there 
are no other related party transactions requiring disclosure. 
 
   12. Going concern 
 
   The Board's assessment of liquidity risk remains unchanged since the 
last Annual Report and Financial Statements for the year ended 30 June 
2019 and is detailed on page 67 of those accounts. The Company has 
adequate cash and liquid resources. The portfolio of investments is 
diversified in terms of sector, and the major cash outflows of the 
Company (namely investments, dividends and share buy-backs) are within 
the Company's control. Accordingly, after making diligent enquiries, the 
Directors have a reasonable expectation that the Company has adequate 
resources to continue in operational existence for the foreseeable 
future. For this reason, the Directors have adopted the going concern 
basis in preparing this Half-yearly Financial Report and this is in 
accordance with the Guidance on Risk Management, Internal Control and 
Related Financial and Business Reporting issued by the Financial 
Reporting Council. 
 
   13. Risks and uncertainties 
 
   The Board considers that the Company faces the following principal risks 
and uncertainties: 
 
   1.   Investment, performance and valuation risk 
 
 
   The risk of investment in poor quality businesses, which could reduce 
the returns to shareholders, and could negatively impact on the 
Company's current and future valuations.  By nature, smaller unquoted 
businesses, such as those that qualify for venture capital trust 
purposes, are more volatile than larger, long established businesses. 
The Company's investment valuation methodology is reliant on the 
accuracy and completeness of information that is issued by portfolio 
companies. In particular, the Directors may not be aware of or take into 
account certain events or circumstances which occur after the 
information issued by such companies is reported. 
 
   To reduce this risk, the Board places reliance upon the skills and 
expertise of the Manager and its track record over many years of making 
successful investments in this segment of the market. In addition, the 
Manager operates a formal and structured investment appraisal and review 
process, which includes an Investment Committee, comprising investment 
professionals from the Manager and at least one external investment 
professional. The Manager also invites and takes account of comments 
from non-executive Directors of the Company on matters discussed at the 
Investment Committee meetings. Investments are actively and regularly 
monitored by the Manager (investment managers normally sit on portfolio 
company boards), including the level of diversification in the portfolio, 
and the Board receives detailed reports on each investment as part of 
the Manager's report at quarterly board meetings. 
 
   The unquoted investments held by the Company are designated at fair 
value through profit or loss and valued in accordance with the 
International Private Equity and Venture Capital Valuation Guidelines. 
These guidelines set out recommendations, intended to represent current 
best practice on the valuation of venture capital investments. The 
valuation takes into account all known material facts up to the date of 
approval of the Financial Statements by the Board. 
 
   2.   VCT approval risk 
 
 
   The Company must comply with section 274 of the Income Tax Act 2007 
which enables its investors to take advantage of tax relief on their 
investment and on future returns. Breach of any of the rules enabling 
the Company to hold VCT status could result in the loss of that status. 
 
   To reduce this risk, the Board has appointed the Manager, which has a 
team with significant experience in venture capital trust management, 
and are used to operating within the requirements of the venture capital 
trust legislation. In addition, to provide further formal reassurance, 
the Board has appointed Philip Hare & Associates LLP as its taxation 
adviser, who report quarterly to the Board to independently confirm 
compliance with the venture capital trust legislation, to highlight 
areas of risk and to inform on changes in legislation. Each investment 
in a new portfolio company is also pre-cleared with our professional 
advisers or H.M. Revenue & Customs. 
 
   3.   Regulatory and compliance risk 
 
 
   The Company is listed on The London Stock Exchange and is required to 
comply with the rules of the UK Listing Authority, as well as with the 
Companies Act, Accounting Standards and other legislation. Failure to 
comply with these regulations could result in a delisting of the 
Company's shares, or other penalties under the Companies Act or from 
financial reporting oversight bodies. 
 
   Board members and the Manager have experience of operating at senior 
levels within or advising quoted companies. In addition, the Board and 
the Manager receive regular updates on new regulation, including 
legislation on the management of the Company, from its auditor, lawyers 
and other professional bodies. The Company is subject to compliance 
checks through the Manager's compliance officer, and any issues arising 
from compliance or regulation are reported to its own board on a monthly 
basis. These controls are also reviewed as part of the quarterly Board 
meetings, and also as part of the review work undertaken by the 
Manager's compliance officer. The report on controls is also evaluated 
by the internal auditors. 
 
   4.   Operational and internal control risk 
 
   The Company relies on a number of third parties, in particular the 
Manager, for the provision of investment management and administrative 
functions. Failures in key systems and controls within the Manager's 
business could place assets of the Company at risk or result in reduced 
or inaccurate information being passed to the Board or to shareholders. 
 
   The Company and its operations are subject to a series of rigorous 
internal controls and review procedures exercised throughout the year, 
and receives reports from the Manager on internal controls and risk 
management, including on matters relating to cyber security. The Audit 
and Risk Committee reviews the Internal Audit Reports prepared by the 
Manager's internal auditor, PKF Littlejohn LLP and has access to the 
internal audit partner of PKF Littlejohn LLP to provide an opportunity 
to ask specific detailed questions in order to satisfy itself that the 
Manager has strong systems and controls in place including those in 
relation to business continuity and cyber security. 
 
   From 1 October 2018, Ocorian (UK) Limited was appointed as Depositary to 
oversee the custody and cash arrangements and provide other AIFMD 
duties. The Board reviews the quarterly reports prepared by Ocorian (UK) 
Limited to ensure that Albion Capital is adhering to its policies and 
procedures as required by the AIFMD. 
 
   In addition, the Board regularly reviews the performance of its key 
service providers, particularly the Manager, to ensure they continue to 
have the necessary expertise and resources to deliver the Company's 
investment objective and policies. The Manager and other service 
providers have also demonstrated to the Board that there is no undue 
reliance placed upon any one individual. 
 
   5.   Economic and political risk 
 
 
   Changes in economic conditions, including, for example, interest rates, 
rates of inflation, industry conditions, competition, political and 
diplomatic events and other factors could substantially and adversely 
affect the Company's prospects in a number of ways. 
 
   The Company invests in a diversified portfolio of companies across a 
number of industry sectors and in addition often invests in a mixture of 
instruments in portfolio companies and has a policy of minimising any 
external bank borrowings within portfolio companies. At any given time, 
the Company has sufficient cash resources to meet its operating 
requirements, including share buy-backs and follow on investments. 
 
   6.   Market value of Ordinary shares 
 
   The market value of Ordinary shares can fluctuate. The market value of 
an Ordinary share, as well as being affected by its net asset value and 
prospective net asset value, also takes into account its dividend yield 
and prevailing interest rates. As such, the market value of an Ordinary 
share may vary considerably from its underlying net asset value. The 
market prices of shares in quoted investment companies can, therefore, 
be at a discount or premium to the net asset value at different times, 
depending on supply and demand, market conditions, general investor 
sentiment and other factors. Accordingly, the market price of the 
Ordinary shares may not fully reflect their underlying net asset value. 
 
   The Company operates a share buy-back policy, which is designed to limit 
the discount at which the Ordinary shares trade to around 5 per cent. to 
net asset value, by providing a purchaser through the Company in absence 
of market purchasers.  From time to time buy-backs cannot be applied, 
for example when the Company is subject to a close period, or if it were 
to exhaust any buy-back authorities. New Ordinary shares are issued at 
sufficient premium to net asset value to cover the costs of issue and to 
avoid asset value dilution to existing investors. 
 
   14. Other information 
 
   The information set out in the Half-yearly Financial Report does not 
constitute the Company's statutory accounts within the terms of section 
434 of the Companies Act 2006 for the periods ended 31 December 2019 and 
31 December 2018 and is unaudited. The financial information for the 
year ended 30 June 2019 does not constitute statutory accounts within 
the terms of section 434 of the Companies Act 2006 and is derived from 
the statutory accounts for the financial year, which have been delivered 
to the Registrar of Companies. The Auditor's report on those accounts 
was unqualified and did not contain statements under s498 (2) or (3) of 
the Companies Act 2006. 
 
   15. Publication 
 
   This Half-yearly Financial Report is being sent to shareholders and 
copies will be made available to the public at the registered office of 
the Company, Companies House, the National Storage Mechanism and also 
electronically at 
https://www.globenewswire.com/Tracker?data=4EQENyfAv-ilXByUn09DjObhkaBQYrn4Aa-2xkvkKxHmJpCLyB1WsnYKoCTFy6fy8aLYhKwrP82-AlEirwe9MZD8I_E-QoTAId65_7tOgn6TBZE93Z5tgInc2BRRtmIl 
www.albion.capital/funds/CRWN. 
 
 
 
   Attachment 
 
 
   -- Investment portfolio by sector as at 31 December 2019 
      https://ml-eu.globenewswire.com/Resource/Download/df136f26-bb32-4074-95f2-4e0473ebbc18 
 
 
 
 
 
 
 

(END) Dow Jones Newswires

February 20, 2020 07:05 ET (12:05 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.
Albion Crown Vct (LSE:CRWN)
Historical Stock Chart
Von Jun 2024 bis Jul 2024 Click Here for more Albion Crown Vct Charts.
Albion Crown Vct (LSE:CRWN)
Historical Stock Chart
Von Jul 2023 bis Jul 2024 Click Here for more Albion Crown Vct Charts.